One of the hypotheses underlying the mechanisms involved in NKp30 down regulation in AML, a chronic exposure to Nkp30 ligands such as B7-H6 or BAG6 has been proposed and demonstrated in other cancers [59]. The gene discussed is NCR3LG1; the disease is acute myeloid leukemia.